[1] 刘丽改, 骆长玲, 王琦, 等. 乙型肝炎肝硬化患者血脂水平与终末期肝病模型评分的相关性分析. 中国临床医生杂志, 2020, 48(10): 1193-1196. [2] 王冰琼, 吴晓宁, 周家玲, 等. 乙型肝炎肝硬化抗病毒治疗后食管静脉曲张转归及其临床特征分析.中华肝脏病杂志, 2022, 30(6): 591-597. [3] O'Shea RS, Davitkov P, Ko CW, et al. Aga clinical practice guideline on the management of coagulation disorders in patients with cirrhosis. Gastroenterology, 2021, 161(5): 1615-1627. [4] D'Avola D, Granito A, Torre-Aláez M, et al. The importance of liver functional reserve in the non-surgical treatment of hepatocellular carcinoma. J Hepatol, 2022, 76(5): 1185-1198. [5] Ibáñez-Samaniego L, Rapado-Castro M, Cabrero L, et al. Hepatitis C eradication improves cognitive function in patients with or without cirrhosis: a prospective real-life study. Eur J Neurol, 2022, 29(2): 400-412. [6] Hiramatsu A, Aikata H, Uchikawa S, et al. Levocarnitine use is associated with improvement in sarcopenia in patients with Liver cirrhosis. Hepatol Commun, 2019, 3(3): 348-355. [7] Tang XL, Miao YD, Mi DH. Comment on "outcomes of curative liver resection for hepatocellular carcinoma in patients with cirrhosis". World J Gastrointest Oncol, 2022, 14(1): 366-368. [8] 中华医学会肝病学分会. 肝硬化诊治指南.实用肝脏病杂志,2019, 22(6): 770-786. [9] Liu B, Zeng Q, Huang J, et al. Ivim using convolutional neural networks predicts microvascular invasion in HCC. Eur Radiol, 2022, 32(10): 7185-7195. [10] Vasylechko SD, Warfield SK, Afacan O, et al. Self-supervised ivim DWI parameter estimation with a physics based forward model. Magn Reson Med, 2022, 87(2): 904-914. [11] Gao P, Liu Y, Shi C, et al. Performing ivim-dwi using the multifunctional nanosystem for the evaluation of the antitumor microcirculation changes. MAGMA, 2020, 33(4): 517-526. [12] Jia H, Jiang X, Zhang K, et al. A nomogram of combining ivim-dwi and mri radiomics from the primary lesion of rectal adenocarcinoma to assess nonenlarged lymph node metastasis preoperatively. J Magn Reson Imaging, 2022, 56(3): 658-667. [13] Yang C, Wei XQ, Zheng J, et al. A correlative study between ivim-dwi parameters and vegf and mmps expression in hepatocellular carcinoma. Quant Imaging Med Surg, 2023, 13(3): 1887-1898. [14] Abdel Razek AAK. Editorial for "preliminary assessment of intravoxel incoherent motion diffusion-weighted mri (ivim-dwi) metrics in alzheimer's disease". J Magn Reson Imaging, 2020, 52(6): 1827-1828. [15] Hu H, Jiang H, Wang S, et al. 3.0 t mri ivim-dwi for predicting the efficacy of neoadjuvant chemoradiation for locally advanced rectal cancer. Abdom Radiol (NY), 2021, 6(1): 134-143. [16] Wen X, Feng X, Kang Y, et al. Application progress of gd-eob-dtpa-enhanced mri t1 mapping in hepatic diffuse diseases. Curr Med Imaging, 2022, 18(12): 1276-1281. [17] Xu J, Wang X, Jin ZY, et al. Assessing liver function by t1 maps on gd-eob-dtpa-enhanced mri for up to 50 min in rat models of liver fibrosis: a longer hepatobiliary time period may help. Chin Med Sci J, 2021, 36(2): 110-119. [18] Dhar D, Baglieri J, Kisseleva T, et al. Mechanisms of liver fibrosis and its role in liver cancer. Exp Biol Med (Maywood), 2020, 245(2): 96-108. [19] Li Q, Chen T, Shi N, et al. Quantitative evaluation of hepatic fibrosis by fibro scan and gd-eob-dtpa-enhanced t1 mapping magnetic resonance imaging in chronic hepatitis B. Abdom Radiol (NY), 2022, 47(2): 684-692. [20] 周玮, 胡红杰, 沈博, 等. 基于钆塞酸二钠增强磁共振成像影像组学定量评估肝硬化患者肝脏储备功能的应用价值. 中国医学科学院学报, 2020, 42(4): 459-467. |